Howard Capital Management »

Taysha Gene Therapies shares owned by Howard Capital Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Howard Capital Management from 13F filings

Historical chart of Howard Capital Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $32k 14k 2.24
2024-03-31 $41k 14k 2.87
2023-12-31 $25k 14k 1.77

More positions owned by Howard Capital Management

Northern Lts Fd Tr Iii Hcm Defnd 100 (QQH)
Northern Lts Fd Tr Iii Hcm Defen 500 (LGH)
Direxion Shs Etf Tr Direxion Hcm (HCMT)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Ishares Tr Core Us Aggbd Et (AGG)
Proshares Tr Ultrapro Qqq (TQQQ)
Broadcom (AVGO)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Russell 2000 Etf (IWM)
Wisdomtree Tr Floatng Rat Trea (USFR)
Proshares Tr Pshs Ultra Qqq (QLD)

View all positions for Howard Capital Management

Top funds holding Taysha Gene Therapies

BlackRock
RA Capital Management
VR Adviser
Morgan Stanley
Vanguard Group
Octagon Capital Advisors
Artal Group
Baker Bros. Advisors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Damian Sousa
T. Rowe Price Associates
Ghost Tree Capital

View all funds holding Taysha Gene Therapies